Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in LIGAND PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 212,888 shares of LGND (LIGAND PHARMACEUTICALS INC), worth $42.5M as of 2026-Q1. The position was decreased (-41.5% shares). LGND represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$42.5M
Current Shares
212,888
Total Value Change
+$38.6M
Total Shares Change
+167,019
Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.
Decreased |
| 212,888 |
-41.5% |
| $42.5M |
| 0.0% |
| $204.24 |
0 |
| 2025-Q4 | Decreased | 363,584 | -3.5% | $68.7M | 0.0% | $190.20 | 0 |
| 2025-Q3 | Decreased | 376,601 | -3.9% | $66.7M | 0.0% | $173.13 | 0 |
| 2025-Q2 | Increased | 391,789 | +608.1% | $44.5M | 0.0% | $114.15 | 47 |
| 2025-Q1 | Increased | 55,327 | +9.8% | $5.8M | 0.0% | $107.62 | 30 |
| 2024-Q4 | Increased | 50,401 | +26.5% | $5.4M | 0.0% | $105.76 | 33 |
| 2024-Q3 | Decreased | 39,838 | -13.2% | $4M | 0.0% | $97.37 | 0 |
| 2024-Q2 | Increased | 45,869 | +191.4% | $3.9M | 0.0% | $84.26 | 43 |